Driehaus Capital Management’s bluebird bio BLUE Stock Holding History

Driehaus Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-105	Closed	-$243K	–	499
2017 Q4	$243K	Buy	+105	New	+$213K	0.01%	494
2017 Q3	–	Sell	-1,296	Closed	-$1.76M	–	488
2017 Q2	$1.76M	Sell	1,296 -2,472	-66%	-$2.98M	0.06%	276
2017 Q1	$4.44M	Buy	3,768 +1,839	+95%	+$1.88M	0.15%	150
2016 Q4	$1.54M	Buy	+1,929	New	+$1.53M	0.05%	297
2015 Q4	–	Sell	-383	Closed	-$425K	–	551
2015 Q3	$425K	Sell	383 -3,300	-90%	-$6.02M	0.02%	445
2015 Q2	$8.03M	Sell	3,683 -2,841	-44%	-$5.79M	0.28%	83
2015 Q1	$10.2M	Buy	6,524 +1,272	+24%	+$1.68M	0.35%	63
2014 Q4	$6.24M	Sell	5,252 -703	-12%	-$470K	0.25%	105
2014 Q3	$2.77M	Sell	5,955 -476	-7%	-$220K	0.11%	255
2014 Q2	$3.21M	Sell	6,431 -4,641	-42%	-$1.49M	0.1%	263
2014 Q1	$3.26M	Buy	+11,072	New	+$3.35M	0.1%	245
2013 Q4	–	Sell	-919	Closed	-$321K	–	469
2013 Q3	$321K	Buy	+919	New	+$341K	0.01%	412

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Driehaus Capital Management's BLUE Position: Q1 2018 in Review

Driehaus Capital Management sold out of bluebird bio (BLUE) in Q1 2018, closing a stake of 105 shares — an estimated $243K sold.

Driehaus Capital Management first reported a position in BLUE in Q3 2013 and held it in 12 quarters. The position peaked at $10.2M in Q1 2015. 303 funds tracked by Wall St. Rank hold BLUE as of Q1 2018.

Driehaus Capital Management reported no remaining bluebird bio position as of Q1 2018 after selling out during the quarter.
Driehaus Capital Management sold 105 bluebird bio shares in Q1 2018, an estimated $243K.
Driehaus Capital Management first reported a position in bluebird bio in Q3 2013 and held it in 12 quarters.
Driehaus Capital Management's bluebird bio position peaked at $10.2M in Q1 2015.
303 funds tracked by Wall St. Rank held bluebird bio as of Q1 2018.

Based on Driehaus Capital Management's 13F filing for Q1 2018, filed 15 May 2018.